| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.09 | 0.05 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.089 | 0.05 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.06 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |